Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- Canadian Cancer Trials Group
- Study ID
- NCT00819208
- Status
- Completed
Conditions
- Anxiety Disorder
- Cognitive/Functional Effects
- Colorectal Cancer
- Depression
- Excercise
- Fatigue
- Psychosocial Effects of Cancer and Its Treatment
- Sleep Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- exercise intervention — BEHAVIORAL3 phases Phase 1: Intensive intervention for 6 months Phase 2: Reduced intervention for months 6-12 Phase 3: Minimal intervention for months 12-36
- counseling intervention — OTHERAchieving an increase in PA from baseline of ≥ 10 MET hours/week will require a significant amount of behavioural support. The intervention will comprise a 36-month individualized PA and behavioural support program with a PAC. This will include a personalized PA prescription which takes into account the baseline fitness test results, PA history, performance status and patient's personal PA preferences and any barriers to activity. Most patients are likely to choose a walking program however any PA of at least moderate intensity level is acceptable.
- educational intervention — OTHEROnce at the beginning of the program
- laboratory biomarker analysis — OTHEREvery 12 months
- questionnaire administration — OTHEREvery 6 months
- study of socioeconomic and demographic variables — OTHEREvery 6 months
- fatigue assessment and management — PROCEDUREEvery 6 months
- quality-of-life assessment — PROCEDUREEvery 6 months
- Educational Intervention — OTHERFor Arm 2 just once at beginning of program.
- Fitness testing — OTHERObjective fitness testing for both arms
Study Details
RATIONALE: Participating in a physical activity program designed to increase free time physical activity and receiving written health education materials may influence the chance of cancer recurring as well as impact on physical fitness, psychological well-being and the quality of life of patients who have undergone surgery and chemotherapy for colon cancer. It is not yet known whether giving a physical activity program together with health education materials is more effective than giving health education materials alone for patients who have undergone colon cancer treatment. PURPOSE: This randomized phase III trial is studying a physical activity program given together with health education materials to see how well it works compared with giving health education materials alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.
Key Dates
- Start date
- Jun 2, 2009
- Status verified
- Apr 2026
- Primary completion
- Feb 7, 2025
- Completion
- Mar 17, 2026
Study Design
- Enrollment
- 889 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Physical Activity Program + General Health Education MaterialsIntervention Arm
- Active Comparator: General Health Education MaterialsControl Arm
Primary Outcome Measure
Disease-free Survival [ Time Frame: 5 Years after randomization ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Henry Ford Hospital | Detroit | Michigan | 48202 | - |
| Dartmouth-Hitchcock | Lebanon | New Hampshire | 03756 | - |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599-1651 | - |
Find similar trials in Detroit, MI
Related Studies
- Registry of Older Patients With CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Boone, North Carolina
- Intern Health StudyEnrolling By Invitation · University of Michigan · Ann Arbor, Michigan
- Internet Based Psychological SupportRecruiting · Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California